Campbell Soup Company (CPB) vs Pfizer Inc. (PFE)
A side-by-side comparison of Campbell Soup Company and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 1, 2026. Differences are shown without an overall score or investment verdict.
Different business models: CPB is classified in Consumer Defensive; PFE is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
CPB
Campbell Soup Company
$21.98Consumer DefensiveAt close: Jul 31, 2026, 4:00 PM ET
PFE
Pfizer Inc.
$25.01HealthcareAt close: Jul 31, 2026, 4:00 PM ET
Total return — CPB vs PFE
growth of $100 · dividends reinvested · last 30yCPB +52.7%PFE +555.6%PFE compounded faster
CPB PFE
CPB vs PFE: by the numbers
- •PFE is the larger company ($142.54B vs $6.55B market cap).
- •CPB trades at the lower trailing earnings multiple (10.83 vs 19.09 P/E), one valuation lens rather than an overall verdict.
- •PFE converts more revenue to profit (11.83% vs 6.12% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 2.65% CAGR).
- •CPB pays the higher dividend yield (7.10% vs 6.88%).
Metrics side by side
Valuation
| Metric | CPB | PFE |
|---|---|---|
| P/E ratio | 10.83 | 19.09 |
| Forward P/E | 10.12 | 8.50 |
| P/S ratio | 0.66 | 2.26 |
| P/B ratio | 1.63 | 1.59 |
| PEG ratio | 2.53 | N/A |
| EV / EBITDA | 8.48 | 9.81 |
| FCF yield | 13.66% | 6.62% |
Profitability
| Metric | CPB | PFE |
|---|---|---|
| Gross margin | 28.85% | 69.35% |
| Operating margin | 11.51% | 23.45% |
| Net margin | 6.12% | 11.83% |
| ROE | 15.09% | 8.31% |
| ROIC | 7.96% | 8.84% |
Dividends
| Metric | CPB | PFE |
|---|---|---|
| Dividend yield | 7.10% | 6.88% |
| Payout ratio | 77.23% | 126.47% |
Growth (annualized)
| Metric | CPB | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 2.65% | 8.22% |
| EPS CAGR (5Y) | -17.80% | -3.78% |
| FCF CAGR (5Y) | -1.86% | -3.79% |
| Total return CAGR (5Y) | -9.36% | -5.29% |
Frequently asked
- Which has the lower trailing P/E, CPB or PFE?
- CPB has the lower trailing P/E: CPB trades at 10.83 and PFE at 19.09. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, CPB or PFE?
- Over the past five years, PFE grew revenue faster — CPB at a 2.65% CAGR versus PFE at 8.22%.
- Does CPB or PFE pay a bigger dividend?
- CPB yields 7.10% and PFE yields 6.88% based on trailing dividends and the latest price.
- Is CPB or PFE more profitable?
- PFE runs the higher net margin — CPB at 6.12% versus PFE at 11.83%.
- How have CPB and PFE total returns compared?
- Over the past 10 years, CPB delivered -6.67% and PFE delivered 1.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Campbell Soup P/E ratioPfizer P/E ratioCampbell Soup dividend yieldPfizer dividend yieldCampbell Soup ROEPfizer ROECampbell Soup operating marginPfizer operating marginCampbell Soup revenue growthPfizer revenue growthCampbell Soup free cash flowPfizer free cash flow
Campbell Soup & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 1, 2026.